Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular era

G Goyal, ML Heaney, M Collin… - Blood, The Journal …, 2020 - ashpublications.org
Erdheim-Chester disease (ECD) is a rare histiocytosis that was recently recognized as a
neoplastic disorder owing to the discovery of recurrent activating MAPK (RAS-RAF-MEK …

The Mayo Clinic Histiocytosis Working Group consensus statement for the diagnosis and evaluation of adult patients with histiocytic neoplasms: Erdheim-Chester …

G Goyal, JR Young, MJ Koster, WO Tobin… - Mayo Clinic …, 2019 - Elsevier
Histiocytic neoplasms, a rare and heterogeneous group of disorders, primarily include
Erdheim-Chester disease, Langerhans cell histiocytosis, and Rosai-Dorfman disease. Due …

Histiocytic neoplasms, version 2.2021, NCCN clinical practice guidelines in oncology

RS Go, E Jacobsen, R Baiocchi, I Buhtoiarov… - Journal of the National …, 2021 - jnccn.org
Histiocytic neoplasms are rare hematologic disorders accounting for less than 1% of cancers
of the soft tissue and lymph nodes. Clinical presentation and prognosis of these disorders …

Histiocytosis and the nervous system: from diagnosis to targeted therapies

F Cohen Aubart, A Idbaih, JF Emile, Z Amoura… - Neuro …, 2021 - academic.oup.com
Histiocytoses are heterogeneous hematopoietic diseases characterized by the accumulation
of CD68 (+) cells with various admixed inflammatory infiltrates. The identification of the …

Erdheim–Chester disease: a rapidly evolving disease model

F Pegoraro, M Papo, V Maniscalco, F Charlotte… - Leukemia, 2020 - nature.com
Erdheim–Chester disease (ECD) is a rare non-Langerhans cell histiocytosis with a putative
neoplastic and inflammatory nature. The disease is driven by mutations in proto-oncogenes …

Spontaneous intracranial hypotension: atypical radiologic appearances, imaging mimickers, and clinical look-alikes

KM Bond, JC Benson… - American Journal …, 2020 - Am Soc Neuroradiology
Spontaneous intracranial hypotension is a condition characterized by low CSF volume
secondary to leakage through a dural defect with no identifiable cause. Patients classically …

Neurologic and oncologic features of Erdheim–Chester disease: a 30-patient series

A Bhatia, V Hatzoglou, G Ulaner, R Rampal… - Neuro …, 2020 - academic.oup.com
Abstract Background Erdheim–Chester disease (ECD) is a rare histiocytic neoplasm
characterized by recurrent alterations in the MAPK (mitogen-activating protein kinase) …

Erdheim–Chester disease

G Starkebaum, P Hendrie - Best Practice & Research Clinical …, 2020 - Elsevier
Erdheim–Chester disease (ECD) is a rare but increasingly recognized multi-system
disorder. Its diagnosis and treatment require integration of clinical information, imaging …

Central nervous system involvement in Erdheim-Chester disease: an observational cohort study

F Cohen Aubart, A Idbaih, D Galanaud, B Law-Ye… - Neurology, 2020 - AAN Enterprises
Objective CNS involvement in Erdheim-Chester disease (ECD) leads to substantial
morbidity and mortality. To assess CNS manifestations in a French cohort of 253 patients …

Erdheim‐Chester disease of brain parenchyma without any systemic involvement: A case report and review of literature

M Aktan Suzgun, E Everest, S Kucukyurt… - …, 2024 - Wiley Online Library
Erdheim‐Chester disease is a non‐Langerhans cell histiocytosis syndrome characterised by
histiocytic infiltration of different organs and systems in the body. Erdheim‐Chester disease …